22UA:ETR
BioNTech SE - ADR
€88.40
0.00%
(0.00) 1D
Sep 4, 2:19:53 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 22UA...
Open
€88.50
High
€89.00
Low
€88.25
Mkt. cap
25.84B
Avg. vol.
59.79K
Volume
7.21K
52-wk high
€105.70
52-wk low
€68.30
No. of employees
8K
Open
€88.50
High
€89.00
Low
€88.25
Mkt. cap
25.84B
Avg. vol.
59.79K
Volume
7.21K
52-wk high
€105.70
52-wk low
€68.30
No. of employees
8K
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
BioNTech's Quiet Reckoning: Capacity Cuts, Shrinking Revenue, and the September Data That Could Sett
Simply Wall Street
·
7 hours ago
BioNTech (BNTX) Stock Looks Above Fair Value As Shares Fell 70%
The Motley Fool
·
14 hours ago
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
Yahoo Finance
·
1 day ago
Is BioNTech Stock a No-Brainer Buy on the Dip?
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR